期刊文献+

晚期肝癌肝动脉灌注化疗(附43例) 被引量:1

下载PDF
导出
摘要 目的:观察晚期肝癌的灌注化疗与传统的全身化疗的疗效比较。方法:对43例晚期肝癌用区域化疗或超选择动脉灌注化疗与21例传统的全身化疗进行疗效比较。结果:动脉化疗疗效高、毒副反应少。结论:对失去手术治疗机会的晚期肝癌患者,肝动脉灌注化疗效果好。
出处 《现代肿瘤医学》 CAS 2006年第10期1306-1306,共1页 Journal of Modern Oncology
  • 相关文献

同被引文献31

  • 1姚连昌,杨仁杰.原发性肝癌化疗用药的现状与展望[J].临床肝胆病杂志,2005,21(1):62-64. 被引量:13
  • 2Leung TW,Tang AM,Zee B,et al.Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin,interferon-alpha,doxorubicin and 5-fluorouracil chemotherapy[J].Cancer,2002,94(9):421-427.
  • 3Kanmematsu T.Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma[J].Hepato Gastroenterol,1996,4(3):1404-1405.
  • 4Poon RT,Ngan H,Lo CM,et al.Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence[J].J Surg Oncol,2000,73(2):109-114.
  • 5Nakashima K,Kinno S,Kim YI,et al.Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma[J].Hepato-gastrorenterology,1996,43(12):1410-1414.
  • 6TakagiK,Koyama T,Hasegawa M.et al.The effect of hepatic arteiral infusion chemotherapy on the prognosis after heparectomy for hepatocellular carcinoma[J].Gan To Kagaku Rycho.1998,25(4):597.
  • 7Ji SK,Park NH,Choi HM,et al.Combined cis-platintum and alpha interferon therapy of a dvanced hepatocellular carcinoma[J].Korean J Intern Med,1996,11(l):58-68.
  • 8Urabe T,Kaneko S,Matsushita E,et al.Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate,5-fluorouracil,cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma[J].Oncology,1998,55(1):39-47.
  • 9Liu CL,Fan ST.Nonresectional therapics for hepatocellular carcinoma[J].Am J Surg,1997,173(4):358-365.
  • 10Levi F.Circadian chronotherapy for human cancers[J].Lancet Oncol,2001,May,2(5):307-315.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部